Tennessee SB2556 requires the Department of Health to report on FDA-approved medications for women's health by January 1, 2027.
Tennessee SB2556 mandates the Department of Health to compile and submit a report on all medications approved by the federal Food and Drug Administration (FDA) for women's health by January 1, 2027. This report, which includes a synopsis of each medication, will be delivered to the Speaker of the Senate and the Speaker of the House of Representatives. The act becomes effective immediately upon becoming law, reflecting the public welfare's necessity.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.